Vishal Gulati

Cure For Hepatitis C Emerges, But Its Not All Good News

September 16, 2015

New England Journal of Medicine reported a study showing that a new antiviral therapy containing sofosbuvir over 12 weeks can eradicate HCV infection in most patients. This is a triumph of science which demonstrates the scale of painstaking and persistent effort it takes to addresss a significant healthcare problem.
To put it in perspective around 150m people, or about 3% of the world’s population, are chronically infected with the hepatitis C virus. Many of these are in their 40s and 50s and current transmission rates are low but each year that passes a proportion of those with infection progress to liver failure which is a significant cost for healthcare systems. Speaking of costs, this therapy is not cheap and has been widely reported

Vishal Gulati on Twitter

New drugs provide cure for hepatitis C, research finds http://t.co/C2M4B4uKBF

Source: http://www.latimes.com/science/la-sci-hepatitis-c-cure-20140412,0,3083638.story?track=rss&utm_source=dlvr.it&utm_medium=twitter#axzz30EJYv9c9